| Literature DB >> 26220620 |
Patricia Regina Manzine1, Elena Marcello, Barbara Borroni, Willem Kamphuis, Elly Hol, Alessandro Padovani, Carla Crispim Nascimento, Patricia de Godoy Bueno, Francisco Assis Carvalho Vale, Sofia Cristina Iost Pavarini, Monica Di Luca, Márcia Regina Cominetti.
Abstract
ADAM10 is a potential biomarker for Alzheimer's disease (AD). ADAM10 protein levels are reduced in platelets of AD patients. The aim was to verify the total blood and platelet ADAM10 gene expression in AD patients and to compare with mild cognitive impairment (MCI) and healthy subjects. No significant differences in ADAM10 gene expression were observed. Therefore, the decrease of ADAM10 protein in platelets of AD patients is not caused by a reduction in ADAM10 mRNA. Further studies must be performed to investigate other pathways in the down regulation of ADAM10 protein.Entities:
Keywords: Aging; biomarkers; blood; platelets
Mesh：
Substances：
Year: 2015 PMID： 26220620 DOI： 10.3109/1354750X.2015.1062554
Source DB: PubMed Journal: Biomarkers ISSN： 1354-750X Impact factor: 2.658